Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai Pharmaceuticals Holding Co., Ltd
  6. Summary
    601607   CNE000000C82

SHANGHAI PHARMACEUTICALS HOLDING CO., LTD

(601607)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
20.35 20.17 19.93 20.22 19.69 Last
11497670 11321720 11359970 13189210 10058870 Volume
+0.54% -0.88% -1.19% +1.46% -2.62% Change
Estimated financial data (e)
Sales 2021 219 B 34 511 M 34 511 M
Net income 2021 5 349 M 844 M 844 M
Net Debt 2021 10 637 M 1 678 M 1 678 M
P/E ratio 2021 10,6x
Yield 2021 2,92%
Sales 2022 243 B 38 396 M 38 396 M
Net income 2022 5 537 M 874 M 874 M
Net Debt 2022 11 586 M 1 828 M 1 828 M
P/E ratio 2022 9,82x
Yield 2022 3,04%
Capitalization 49 761 M 7 850 M 7 851 M
EV / Sales 2021 0,28x
EV / Sales 2022 0,25x
Nbr of Employees 48 136
Free-Float 61,4%
More Financials
Company
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The Company's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The Company's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system,... 
Sector
Drug Retailers
Calendar
03/25Earnings Release
More about the company
Ratings of Shanghai Pharmaceuticals Holding Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
01/13Aurora Mobile Expands Partnership With Shanghai Pharmaceuticals
MT
2021Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Nine Months ..
CI
2021Shanghai Pharmaceuticals Holding Co., Ltd Reports Earnings Results for the Half Year En..
CI
2021SHANGHAI PHARMACEUTICALS : Pharma Successfully Files Application for Share Placement with ..
MT
2021SHANGHAI PHARMACEUTICALS : Pharma Shareholders to Vote Aug. 12 on $2.2 Billion Fundraising..
MT
2021SHANGHAI PHARMACEUTICALS : Reply slip for holders of h share attending the extraordinary g..
PU
2021Shanghai Pharmaceuticals Holding Co., Ltd Announces Executive Changes
CI
2021SHANGHAI PHARMACEUTICALS HOLDING CO. : Ex-dividend day for final dividend
FA
2021SHANGHAI PHARMACEUTICALS : The Fortune 500 company Shanghai Pharmaceuticals enters the den..
AQ
2021Shanghai Pharmaceuticals Holding Co., Ltd acquired Fimet Oy for approximately CNY 200 m..
CI
2021Shanghai Pharmaceuticals Holding Co., Ltd Approves Cash Dividend for the Year 2020, Pay..
CI
2021SHANGHAI PHARMACEUTICALS : Pharma to Buy Medical Equipment Maker From Affiliate for Nearly..
MT
2021Shanghai Industrial Urban Unit to Provide Project Management Services to Shanghai Pharm..
MT
2021Shanghai Pharmaceuticals Holding Co., Ltd entered into an equity transfer agreement to ..
CI
2021Shanghai Pharmaceuticals Holding Co., Ltd. Announces Obtaining Acceptance of Applicatio..
CI
More news
News in other languages on SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
2021Shanghai Pharma dépose avec succès une demande de placement d'actions auprès du régulat..
2021Les actionnaires de Shanghai Pharma voteront le 12 août sur une proposition de collecte..
2021Shanghai Pharmaceuticals Holding Co., Ltd approuve le dividende en espèces pour l'année..
2021Shanghai Pharma rachète un fabricant d'équipements médicaux à une société affiliée pour..
2021CanSino Bio et Shanghai Pharma injectent 171 millions de dollars de financement supplém..
More news
Chart SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Duration : Period :
Shanghai Pharmaceuticals Holding Co., Ltd Technical Analysis Chart | 601607 | CNE000000C82 | MarketScreener
Technical analysis trends SHANGHAI PHARMACEUTICALS HOLDING CO., LTD
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 19,69 CNY
Average target price 21,39 CNY
Spread / Average Target 8,61%
EPS Revisions
Managers and Directors
Man Cho President & Executive Director
Bo Shen Chief Financial Officer, Executive Director & VP
Jun Zhou Chairman
Liang Hong Independent Non-Executive Director
Jiang Nan Cai Independent Non-Executive Director